These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4877327)

  • 41. Accessory cells in the in vitro generation of type C virus-specific T killer lymphocytes. II. Demonstration of a T helper cell in the spleen of in vivo primed mice.
    Gomard E; Wybier-Franqui J; Simmler MC; McKenzie IF; Levy JP
    J Immunol; 1981 Dec; 127(6):2291-5. PubMed ID: 6170695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Fluorescent antibody technic in Friend virus--infected tumor cells in rats].
    Saito H; Takeichi N; Sendo F; Kaji H; Kobayashi H
    Saishin Igaku; 1970 Nov; 25(11):2376-82. PubMed ID: 4920652
    [No Abstract]   [Full Text] [Related]  

  • 43. Murine leukemia and its viruses.
    Rich MA
    Natl Cancer Inst Monogr; 1966 Sep; 22():425-37. PubMed ID: 4288565
    [No Abstract]   [Full Text] [Related]  

  • 44. Properties of transformed hemopoietic cells in mice infected with the Friend virus complex.
    Steeves RA; Mirand EA; Thomson S
    Bibl Haematol; 1970; (36):624-33. PubMed ID: 5538366
    [No Abstract]   [Full Text] [Related]  

  • 45. Survival of mouse skin isografts from leukemic donors.
    Meeker WR; Mirand EA; Grace JT
    J Surg Oncol; 1969; 1(1):19-22. PubMed ID: 4939633
    [No Abstract]   [Full Text] [Related]  

  • 46. Accessory cells in the in vitro generation of type C viruses specific T killer lymphocytes. I. Role of macrophages in primary anti-FMR reaction.
    Gomard E; Wybier-Franqui J; Levy JP
    J Immunol; 1981 Mar; 126(3):891-6. PubMed ID: 6257785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Nature of the target cells for Rauscher and Friend leukemia viruses].
    Sanin AV; Khorobrykh VV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1980; (8):5-20. PubMed ID: 6996749
    [No Abstract]   [Full Text] [Related]  

  • 48. Transplantation immunity and the suppression of spleen colony formation by immunization with murine leukemia virus preparations (Friend).
    Friend C; Rossi GB
    Int J Cancer; 1968 Jul; 3(4):523-9. PubMed ID: 5682446
    [No Abstract]   [Full Text] [Related]  

  • 49. [Growth mechanism of rat Friend tumor (RFT--immunological characteristics of the rat inoculated with Friend virus in neonatal period].
    Takeichi N; Shirai S; Hosokawa M; Kobayashi H
    Saishin Igaku; 1970 Jan; 25(1):177-82. PubMed ID: 4910737
    [No Abstract]   [Full Text] [Related]  

  • 50. Production of a potent complement-fixing murine leukemia virus-antiserum from the rabbit and its reactions with various types of tissue culture cells.
    Schäfer W; Seifert E
    Virology; 1968 Jun; 35(2):323-8. PubMed ID: 4298714
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
    Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
    Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Extraction and purification of tumoral neo-antigens obtained from splenic cells and serum of mice with Charolotte Friend's leukemia].
    Martyré MC; Halle-Pannenko O
    Rev Fr Etud Clin Biol; 1968 Dec; 13(10):1010-2. PubMed ID: 5734068
    [No Abstract]   [Full Text] [Related]  

  • 53. Neutralization of sublines of a mouse leukemia virus with murine antibody, as measured by the spleen focus assay.
    Sinkovics JG; Pienta RJ; Fiorentino M; Bertin BA
    Cancer Res; 1967 Jan; 27(1):88-94. PubMed ID: 6020368
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of pyran copolymer on oncogenic virus infections in immunosuppressed hosts.
    Hirsch MS; Black PH; Wood ML; Monaco AP
    J Immunol; 1972 May; 108(5):1312-8. PubMed ID: 4337673
    [No Abstract]   [Full Text] [Related]  

  • 55. Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses.
    Cianciolo GJ; Matthews TJ; Bolognesi DP; Snyderman R
    J Immunol; 1980 Jun; 124(6):2900-5. PubMed ID: 6246170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of Friend leukemogenic virus on antibody-forming cells to a bacterial somatic antigen.
    Hirano S; Ceglowski WS; Allen JL; Friedman H
    J Natl Cancer Inst; 1969 Dec; 43(6):1337-45. PubMed ID: 4918854
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic and cellular basis of susceptibility or resistance to Friend leukemia virus infection in mice.
    Axelrad A
    Proc Can Cancer Conf; 1969; 8():313-43. PubMed ID: 5792937
    [No Abstract]   [Full Text] [Related]  

  • 59. Macrophage involvement in leukemia virus-induced tumorigenesis.
    Bendinelli M; Matteucci D; Toniolo A; Friedman H
    Adv Exp Med Biol; 1979; 121B():493-508. PubMed ID: 232621
    [No Abstract]   [Full Text] [Related]  

  • 60. [Physico-chemical and immunologic properties of the tissue DNA of mice with oncornavirus-induced leukemia].
    Chamova KG; Perelaznyĭ AA; Guseva NI
    Biull Eksp Biol Med; 1981 Jul; 92(7):60-2. PubMed ID: 6170360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.